Anti-tumor medication therapy usually elevates ROS, which causes DNA damage and death by decreasing the mitochondrial membrane potential, resulting in the release of cytochrome C, activation of caspase3, increased BAX expression and reduced Bcl2 expression [61]. This evidence concerns the gene BCL2 and neoplasm.